Invokamet 50 mg / 500 mg Oral Tablet
RxNorm 1545166
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1545166 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Invokamet 50 mg / 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Canagliflozin 50 mg / metformin hydrochloride 500 mg Oral Tablet [Invokamet]
(Atom ID: 12361272)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Canagliflozin 50 mg / metFORMIN hydrochloride 500 mg Oral Tablet [Invokamet]
(Atom ID: 6392591)
SYPrescribable
Synonym (SY):
Invokamet (canagliflozin 50 mg / metformin hydrochloride 500 mg) Oral Tablet
(Atom ID: 6391855)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Invokamet (canagliflozin 50 mg / metFORMIN hydrochloride 500 mg) Oral Tablet
(Atom ID: 6392592)
PSNPrescribable